November 27, 2015
Recommended Topic Related To:


"Oct. 17, 2012 -- A drug used to treat psoriasis may provide a much-needed option for people with bad cases of Crohn's disease.

In the new study, some people with moderate to severe Crohn's given Stelara (ustekinumab) began to see imp"...




There have been no reported cases of overdosage with OsmoPrep Tablets. Purposeful or accidental ingestion of more than the recommended dosage of OsmoPrep Tablets might be expected to lead to severe electrolyte disturbances, including hyperphosphatemia, hypocalcemia, hypernatremia, or hypokalemia, as well as dehydration and hypovolemia, with attendant signs and symptoms of these disturbances. Certain severe electrolyte disturbances resulting from overdose may lead to cardiac arrhythmias, seizure, renal failure, and death. The patient who has taken an overdosage should be monitored carefully, and treated symptomatically for complications until stable.


OsmoPrep Tablets are contraindicated in the following conditions:

  • Biopsy-proven acute phosphate nephropathy
  • Gastrointestinal (GI) obstruction
  • Gastric bypass or stapling surgery
  • Bowel perforation
  • Toxic colitis
  • Toxic megacolon
  • Known allergy or hypersensitivity to sodium phosphate salts or any component of OsmoPrep [see DESCRIPTION].
This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 10/25/2012


OsmoPrep - User Reviews

OsmoPrep User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication OsmoPrep sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

GI Disorders

Get the latest treatment options.